Rallybio Corp
Ticker: 1739410
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 0.21+0.0% | 0.21+0.0% | 0.21+0.0% | 0.21-30.0% | 0.30+0.0% | 0.30 |
| Total Income | 0.21+0.0% | 0.21+0.0% | 0.21+0.0% | 0.21-30.0% | 0.30+0.0% | 0.30 |
| EXPENSES | ||||||
| Expenditure | 8.95+25.4% | 7.14-30.5% | 10.27+3.9% | 9.88-20.1% | 12.37-28.6% | 17.33 |
| PROFIT | ||||||
| PBT | -8.28-151.7% | 16.02+270.1% | -9.42-6.4% | -8.85+18.3% | -10.83+31.2% | -15.75 |
| Net Profit | -8.28-151.7% | 16.02+265.2% | -9.70-2.8% | -9.44+17.7% | -11.47+29.4% | -16.24 |
| KEY METRICS | ||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00%-200.00pp | 100.00%+200.00pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -1.46-505.6% | 0.36+263.6% | -0.22-4.8% | -0.21+19.2% | -0.26+29.7% | -0.37 |
Corporate Events
Board MeetingRLYB
202631May
Board Meeting
Rallybio Corporation entered into a merger agreement to acqu…
SEC Filing ↗